ECCMID has become one of the most comprehensive and influential congresses in the field of infection and an exciting networking place bringing together >14,000 colleagues from all over the world. Share and discuss your research with colleagues from around the world.

ESCMID would like to extend our thanks to our scientific community for the overwhelming response to the call for abstracts for ECCMID 2021, despite the challenging times. This rich selection of scientific work ensures that the congress will be extremely lively and diverse!

Latebreaker abstracts will be accepted from 26 April - 7 May 2021.

For the latebreaking abstract call, we welcome high-quality abstracts containing novel data that became available only after the end of February 2021 (close of regular call) in the following categories:

- New Drugs

- Clinical trial results

- Innovations concerning COVID-19

- Public health emergencies other than COVID-19

As an exception this year, the submission of high-quality regular research abstracts is allowed during the late-breaker call, for members of our community who could not prepare and submit their work during the regular call, due to involvement in the pandemic response.

For this category the normal guidelines will be applicable, which can be found here, however submissions in the above-mentioned latebreaker categories are encouraged, and will be treated with priority.

The full latebreaker abstract guidelines will be published in mid-March.

If you have any questions or need any assistance, please do not hesitate to contact us at eccmidabstracts[at]escmid.org.